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Introduction:  Because  the  extreme  diversity  of  clinical  situations  makes  formal  clinical  trials  difﬁcult
to  carry out,  animal  models  of  periprosthetic  infection  in orthopaedics  are needed  to understand  the
aetiology  and  pathology  of these  infections,  and  to test  new  treatment  methods.  These  experimental
models  must  reproduce  the  features  of  the  infections  encountered  in clinical  practice.  One  of  the  model
variables  is the  method  of  inoculation:  local  (intra-articular),  intravenous  or intra-arterial.  Another  is the
timing of  the  inoculation:  intra-operative  or postoperative.  Together,  these  options  simulate  the different
contamination  methods:  direct,  by  proximity  or blood-borne.  However,  the  chosen  inoculation  route  can
also  affect  the  infection  rate  and  severity  in the  various  models,  and  in some  cases  do  not  accurately
reproduce  the  postoperative  infections  encountered  clinically.
Hypothesis:  The  direct  inoculation  method  is  the  most  effective  for inducing  a  local  infection  on  a foreign
body  in  a joint,  and  the  least  iatrogenic.
Methods:  A critical  analysis  of published  studies  was  carried  out to evaluate  each  model  against  three
endpoints,  according  to the  type  of  inoculation.  The  primary  endpoint  was the  infection  rate,  which  should
be  as  close  as  possible  to 100%.  The  secondary  endpoints  were  the  mortality  rate  and  rate  of  spontaneous
healing,  both  of which  should  be as low  as possible.  Twenty-one  articles  were  reviewed.
Results:  Intra-articular  and  intra-medullary  inoculations  had induction  rates  between  70 and  100%;  intra-
arterial inoculations  had  an  induction  rate  of 100%,  while  intravenous  inoculation  had  a  rate  of  47 to
77%.  The  mortality  rates  were  lower  with  the  intra-articular  and intramedullary  inoculations  (5  to  23%)
than for  the intra-arterial  inoculations  (37%)  and  intravenous  inoculations  (28 to  56%).  The  spontaneous
healing  rate  was  0 to  30%  for  intra-articular  and  intramedullary  inoculations,  30  to 53%  for  intravenous
inoculations  and  0%  for intra-arterial  inoculations.
Conclusion:  Direct  inoculation  methods  are  most  effective  at reproducing  chronic  periprosthetic  joints
infections,  without  putting  the animal’s  life  at risk  or allowing  for spontaneous  healing.  The  simulation
of  blood-borne  infections  is  more  random.
© 2015  Elsevier  Masson  SAS.  All  rights  reserved.. Introduction
Many animal models have been created to study musculoskele-
al infections, particularly ones that reproduce osteomyelitis. Most
f the models are based on Norden’s work [1] in the late 1970s.
xtrapolations have been made from this initial model to helps
s better understand periprosthetic joint infections (PJI) [2]. These
∗ Corresponding author. Tel.: +33 06 76 73 38 82.
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http://dx.doi.org/10.1016/j.otsr.2015.08.007
877-0568/© 2015 Elsevier Masson SAS. All rights reserved.infections are a major issue because of the increasing number of
prostheses being implanted. Each year, more than 200,000 joint
prostheses are implanted in France, with 1 to 1.5% becoming
infected. Staphylococcus is the most prevalent bacterial species
implicated [3]. However, the clinical scenarios vary greatly, making
it difﬁcult to plan comparative or even randomized clinical trials.
Animal models are good for studying the prophylactic and
therapeutic effects of antibiotics on prosthesis-related infections
because infections can be induced homogeneously and repro-
ducibly under experimental conditions. They help us understand
the pathophysiology of PJI and to test new treatments, such as
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ystemic antibiotics, antibiotic-loaded bone cements and implant
oatings. For these models to be applicable to humans, they must
eproduce the infection method and progression of the human
JI as closely as possible, namely the absence of spontaneous
ealing and progression to chronic infection, while being repro-
ucible and easy to carry out. In addition, they must be ethically
cceptable (approved by research ethics committee) and low cost.
ne of the important considerations is the method of inocula-
ion: intra-operative intra-articular, postoperative intra-arterial
nd intravenous (blood-borne) or by proximity (intramedullary).
ach type of inoculation simulates one of the various contamina-
ion methods encountered during clinical practice. For example,
ocal inoculation (intra-articular) is the inoculation method that
est reproduces the conditions of nosocomial infection, which is
he most common type of infection. It is attributed to direct con-
amination of the surgical wound or implant. No matter its form,
noculation should consistently produce an infection that is likely to
ecome chronic, without leading to the animal’s death. This repro-
uces the features of most PJIs in humans. This led us to evaluate the
ontamination method used in all published PJI models, which was
lassiﬁed using certain criteria. First, the contamination must result
n a 100% or nearly 100% infection rate. Second, the rate of mortality
nd spontaneous healing must be as close to 0% as possible.
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We  hypothesized that the direct inoculation method was the
most effective for inducing a local infection on a foreign body in
the joint, and the least iatrogenic.
2. Material and methods
A search was  performed using PubMed to identify relevant arti-
cles using the keywords experimental or model + joint + infection or
periprosthetic + infection (Fig. 1).
Articles were included if they featured an orthopaedic peripros-
thetic joint infection model.
Articles were excluded when:
• the infection did not reproduce a PJI, in particular models of
subcutaneous cage implantation that reproduce a foreign body
infection that is dissimilar to PJI in humans because of subcuta-
neous abscess is formed that does not infect the bone or joint
[3,4];
• the model induced osteomyelitis without arthritis.Twenty-one articles were retained and analysed that encom-
passed nine different models of PJI [5–25]: 7 in rabbits, 1 in mice,
and 1 in rats.
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Table  1
Comparison of different animals models by inoculation method (NZW: New Zealand white, PJI: periprosthetic joint infection).
Type of inoculation First author Year of
publication
Microorganism
used
Implant used Type and number of animals
used
Goal of study
Intra-operative
intra-articular
Schurman [6] 1978 Escherichia coli Hemiarthroplasty of
knee: cement and
stainless steel cylinder
in femur
30 NZW rabbits Test efﬁcacy of gentamicin
cement and duration of this
effect
Craig [10] 2005 Methicillin-
resistant S.
aureus
Hemiarthroplasty of
knee: cement around
screw in distal femur
22 NZW rabbits Development of model for PJI
Bernthal [13]
Niska [14]
2010 [13]
2013 [14]
S. aureus Stainless steel K-wires
in distal femur (distal
end placed
intra-articular)
12 mice
8 mice
[13] evaluate the efﬁcacy of
resorbable polymer loaded
with rifampicin and
minocycline for preventing PJI
[14] evaluate the beneﬁts of
combining vancomycin and
rifampicin for treating S.
aureus infection of joint
implants
Our  model
[5,16–25]
1996–2011 S. aureus Hemiarthroplasty of
right knee: silicone
implant
NZW rabbits
[5] 35 animals, [16] 20 animals,
[17] 31 animals, [18] 13
animals, [19] 20 animals, [20]
52 animals, [21] 45 animals,
[22] 52 animals, [23] 11
animals, [24] 56 animals, [25]
66 animals
Model development [5],
antibiotic testing
[16,17,20–22,25], evaluation of
diagnostic methods [18,19],
evaluation of bioactive
polymers [23],  evaluation of
antibiotic-loaded cements [24]
Intra-articular
intramedullary
Southwood [9] 1985 S. aureus Hemiarthroplasty of
hip: femoral
component with ball
bearings and cemented
pins
125 short-haired rabbits Demonstrate reduced
resistance to infection in the
presence of foreign body
Alt  [11] 2006 S. aureus Tibial intramedullary
locked nail (distal end
placed intra-articular)
30 NZW rabbits Test implant coatings, some of
which were gentamicin
impregnated
Antoci [15] 2007 S. aureus Titanium
nail ± vancomycin
coating in distal femur
(distal end placed
intra-articular)
24 Wistar Rats Test beneﬁts of using
vancomycin coating for
preventing PJIs
Postoperative
intravenous
Blomgren [7]
Blomgren [8]
1980
1981
S. aureus Total knee arthroplasty
(cemented femoral and
tibial components)
23 NZW rabbits in each study [7] study the postoperative
dissemination of bacteria in the
blood after joint replacement
[8] test effectiveness of
gentamicin cement
Southwood [9] 1985 S. aureus Hemiarthroplasty of
hip: femoral
component with ball
bearings and cemented
pins
125 short-haired rabbits Demonstrate reduced
resistance to infection in the
presence of foreign body
Postoperative
intra-arterial
Poultsides [12] 2008 S. aureus Porous tantalum
implant in proximal
tibia (proximal end
 intra-
30 NZW rabbits Development of model for PJI
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taphylococcus aureus:  S. aureus.
Each article was analysed to determine the method of inocula-
ion, bacterium used, surgical technique (and more generally the
ethods, including ethics approval), resemblance of the PJI to the
uman condition (particularly in terms of function, bone appear-
nce and absence of spontaneous healing), and the goal of the study
development of model, test of local or systemic antibiotics, etc.)
Table 1).
Four methods of inoculation were found:
intra-operative intra-articular inoculation [5,6,10,13,14,16–25].
This consisted of injecting the inoculum (0.1 to 0.5 ml  depending
on the protocol) into the joint after a device had been implanted
(Table 1) and the skin closed; a 1 cc syringe with a 16G needle
was used in these cases;
intra-operative intramedullary inoculation [9,11,15]. This
consisted of injecting the inoculum into the bone’s medullary
canal before implantation, at the time of the diaphysealarticular)
catheterization (generally using a syringe with a 16G needle,
and injecting 0.002 to 0.1 ml  of bacterial suspension, depending
on the animal species);
• postoperative intravenous inoculation [7–9]. This consisted of
injecting the inoculum (1 ml  bacterial suspension) in a periph-
eral vein (ear vein in rabbits) after implantation using a 22–24G
catheter;
• postoperative intra-arterial inoculation [12]. This consisted of
injecting the inoculum into the femoral artery after implantation;
this method required exposing the femoral artery 2 cm above the
knee joint and then introducing a 26G catheter to inject 1 ml  of
bacterial suspension.For all the models, independent of the method of inoculation,
the infection diagnosis was  made based on microbiological analysis
(particularly, bacterial counts) of the bone harvested during the
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Table 2
Comparison of infection, mortality and spontaneous healing rates in the various animal models found in the literature search.
Type of inoculation First author Year of publication Infection rate (in
controls if
antibiotics being
tested) (%)
Mortality rate Spontaneous
healing rate (%)
Intra-operative intra-articular Schurman [6] 1978 81 9% 19
Craig  [10] 2005 75 5% 25
Bernthal [13] 2010 [13] 100 Not speciﬁed 0
Niska [14] 2013 [14] 77 Not speciﬁed 23
Our  own model
[5,16–25]
1996–2011 93 23% (average mortality
rate when speciﬁed)
7
Intra-operative intramedullar Southwood [9] 1985 70 17% 30
Alt  [11] 2006 88 11% 12
Antoci [15] 2007 100 Not speciﬁed 0
Postoperative intravenous Blomgren [7] 1980 50 56% 50
Blomgren [8] 1981 70 Not speciﬁed 30
Southwood [9] 1985 47 28% 53
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nimals’ autopsy. In most studies, the diagnosis was supplemented
ith histological or radiographical analysis.
. Results
Local injection of the inoculum (intra-articular or
ntramedullary) was the method of the inoculation that led
o the highest infection rate (75–100% for intra-articular and
0–100% for intramedullary) and the lowest mortality rate
Table 2). Even though the mortality rate was not always reported
5,8,13–15,20–22,24,25], it was estimated to be 5 to 23% for
ntra-articular inoculation [6,10,16–19,23], and 11 to 17% for
ntramedullary inoculation [8,10]. In our own  rabbit model
f intra-articular inoculation [5,16–25], the number of deaths
ncreased when rifampicin was given; the observed 23% rate in the
ast study was due to profuse diarrhoea in rabbits (non-published
ata).
The spontaneous healing rate was 0 to 25% for intra-articular
noculation and 0 to 30% for intramedullary inoculation.
The other inoculation methods, namely intravenous and intra-
rterial, produced lower infection rates (47–70% infection rate after
V inoculation with 30–53% spontaneous healing, possibly due to
 lavage effect of rabbit serum) or led to excess mortality (37% for
ntra-articular and 28–56% for intravenous inoculation).
. Discussion
Direct local inoculation (either intramedullary or intra-
rticular) is the most effective inoculation method in studies of
hronic PJIs, resulting in a high infection rate and low mortality
ate relative to the other methods of inoculation. The other meth-
ds (intra-arterial and intravenous) led to higher mortality rate,
robably due to the technical challenges associated with arterial
atherization in the lower limbs of small animals and likely bacter-
emia with severe secondary infection [9]. This may  explain why
ew studies have been published with these methods of inoculation.
Although the direct inoculation model does not simulate blood-
orne infections, it makes it possible to study the large majority of
arly PJIs. For this reason, it has been used during animal model
evelopment, study of the pathophysiology of infection and also
reatments.
The implant used is an important element to consider, particu-
arly because of bioﬁlm formation. It would be interesting to test
ew materials or materials that resemble those used in humans.100 37% 0
Other variables affect the infection rate, mortality rate and
spontaneous healing rate, such as the animal species and type of
microorganism.
Most of the models reviewed use rabbits because of their
reactions to infection, which mimic human joint infections (inﬂam-
matory scar, skin ﬁstula, osteitis on radiographs, reduced joint
range of motion) and the ease of performing surgical procedures
on them, including joint replacement [26]. The pharmacokinetics
of antibiotics in rabbits in close to that of humans, making it possible
to evaluate new treatments and other pathophysiological features,
such as the effect of the virulence of Staphylococcus aureus in vivo.
And ﬁnally, these animals are more susceptible to infection than
rats or mice, and do not cost too much, especially in comparison
to large animals such as sheep and pigs [27]. However, they have
poor digestive tolerance to certain antibiotics (namely rifampicin),
which can induce severe diarrhoea and cause elevated mortality.
Most models use a strain of S. aureus because this is a very com-
mon  pathogen found in musculoskeletal infections, particularly in
PJIs in humans. There is joint and bone tropism, which is the sub-
ject of other studies. But other bacteria can cause certain PJIs, and
the strains used do not necessarily represent the causative agents
in humans [28]. The main limitation of this review is that none
of the models used a strain of coagulase-negative staphylococci,
which is common in humans [29]. The goal of developing mod-
els of PJI in animals revolves around the possibility of studying
the pathophysiology of such infections, and the treatment possi-
bilities that ensue. This requires research into the microorganisms
representative of the bacterial population found in musculoskele-
tal infections in humans. Moreover, the use of different species of
animals and different types of implants can make it difﬁcult to com-
pare the various models; this is another important limitation of this
review.
5. Conclusion
Direct inoculation is the most effective experimental contam-
ination method used to obtain a PJI, but this procedure does not
model infection disseminated through the blood or by proxim-
ity. Experimental models of blood-borne infections are trickier to
implement, and they induce lower infection rates and excessive
mortality.Funding
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